+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

DelveInsight - Market Research Reports

Delve Insight authors market leading reports across the pharmaceutical and biotechnology sectors. The key findings and insights all come from regular monitoring of developments through the pharmaceutical and biotechnology sectors. These findings are then published through market forecasts, drug pipelines and drug insights, along with advice from top market analysts on how to best use this, alongside the detailed market forecasts offered by Delve Insight.

Alpha V Beta 3/5/6 Integrin Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha V Beta 3/5/6 Integrin Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha V Beta 3 Integrin Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha V Beta 3 Integrin Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Myostatin Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Myostatin Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
GABA Transaminase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

GABA Transaminase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha-1 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-1 Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
VAP-1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

VAP-1 Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cholecystokinin Receptor (CCK) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Cholecystokinin Receptor (CCK) Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Angiopoietin Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Angiopoietin Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
DNA Methyltransferase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

DNA Methyltransferase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Renin Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Renin Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Beta Selective Thyroid Hormone Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta Selective Thyroid Hormone Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Beta Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Angiotensin Modulators - Pipeline Insight, 2025 - Product Thumbnail Image

Angiotensin Modulators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
20s Proteasome Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

20s Proteasome Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Non Selective COX Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Non Selective COX Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
G2 Checkpoint Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

G2 Checkpoint Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Fibroblast Growth Factor 1 (FGF-1) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Fibroblast Growth Factor 1 (FGF-1) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator